April is Head neck cancer awareness month. Head and neck cancers aren’t just random, they’re often tied to things you can be aware of and act on. The more you understand the risks, the better you can ...

Through an international joint research, a Korean research team developed the world's first pre-stage lesion (pre-cancer lesion) that implements the world's first pre-stage head and neck cancer lesion ...

A systematic review published in Discover Oncology explores the anticancer efficacy of medicinal plant extracts in treating Oral Squamous Cell Carcinoma (O | Plants And Animals ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Full abstract details including title and text are currently available to registrants via the AACR online itinerary planner. A copy of the presentation will be available in the Posters and ...

Ziftomenib has received Breakthrough Therapy, Fast Track, and Orphan Drug Designations. The FDA has a 60-day filing review period to determine whether the NDA is complete and accepted for review; Kura ...

Tagrisso (osimertinib) and Lazcluze (lazertinib) are oral epidermal growth factor receptor (EGFR ... tested in clinical trials for when this occurs. For those with squamous cell carcinoma of the lungs ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...